Leveraging IVD Service Providers for Compliance and Device Integration
Entering the U.S. market with a new diagnostic device can be complex—but it doesn’t have to be chaotic. In this talk delivered during MEDICA 2024, Dr. Patrick Vaughan, Chief Operating Officer of DCN Dx, shares practical strategies for navigating regulatory requirements, optimizing study design, and integrating devices efficiently.
Drawing on DCN Dx’s experience supporting hundreds of IVD products, the presentation outlines how developers can accelerate timelines and reduce risk by leveraging the right service providers, particularly during critical development and regulatory phases.
Why You Should Download
1. Gain clarity on U.S. regulatory pathways.
Dr. Vaughan breaks down common misconceptions about the FDA process, including when and how to engage in pre-submission discussions.
2. Understand how to integrate devices, readers, and data systems.
Learn how to approach reader integration and connectivity in a way that aligns with both regulatory expectations and user experience needs.
3. See real-world examples from successful IVD programs.
From CLIA-waived assays to EU-to-U.S. transitions, this presentation shares insights drawn from actual client engagements.
4. Discover how to leverage IVD CROs and CDMOs strategically.
Find out when to bring in external expertise—and how to choose service providers that will protect your IP, accelerate development, and deliver usable outputs.
5. Walk away with actionable takeaways.
This is not a generic overview. It’s a focused, practical session for diagnostics professionals serious about U.S. market success.
